Abdul Hanan: Why Do Patients with Immune TTP Behave Differently ?
Abdul Hanan, Clinical Fellow in Transfusion, Hemostasis and Apheresis Medicine (THAM) at The University of Chicago Medicine, reposted from JTH on LinkedIn:
”Food for thought – Why do patients with immune TTP behave differently despite sharing the same diagnosis?
Emerging evidence suggests that anti-ADAMTS13 antibodies differ not only in quantity but also in how they inhibit ADAMTS13 function. Interesting study offering fascinating insights into the complexity of immune TTP and the future of personalized patient care.”
Quoting Journal of Thrombosis and Haemostasis (JTH)‘s post about a recent article by Chan Meng et al:
”Human monoclonal and polyclonal anti-ADAMTS13 antibodies in immune thrombotic thrombocytopenic purpura: variable mechanisms of inhibition
Antibodies against ADAMTS13 cause immune thrombotic thrombocytopenic purpura, but how they disable the enzyme varies.
This work shows inhibition depends on the reaction conditions and differs between patients, and that antigen depletion is probably not the main mechanism in most cases.
The findings suggest current diagnostic assays may underestimate how often iTTP truly occurs.”
Title: Human monoclonal and polyclonal anti-ADAMTS13 antibodies in immune thrombotic thrombocytopenic purpura: variable mechanisms of inhibition
Authors: Chan Meng, Konstantine Halkidis, Madison Gil, Szumam Liu, X. Long Zheng
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 10, 2026, 07:26Carly Newton: Every Donation Helps Save Lives
-
Sep 10, 2026, 07:152023 ACR/EULAR APS Classification Criteria – APS Foundation of America
-
Sep 10, 2026, 07:03When Platelet Function Matters More Than Platelet Count – Glanzmann’s Research Foundation
-
Sep 10, 2026, 06:54Diego López Santos: Young Blood Donors Unite at the 23rd International Youth Forum in Tirana
-
Sep 10, 2026, 05:12Douglas S. Campbell: Great to See a Strong Japanese Presence in 2026 Lasker Awards
-
Sep 10, 2026, 05:11Jan Hartmann: New Transformative Treatment for Hemophilia A
-
Sep 10, 2026, 05:09Shelby Bradford: Award-Winning Science Incoming
-
Sep 9, 2026, 17:57CRISPR/Cas Gene Editing in β-Thalassemia: From Molecular Correction to Clinical Reality
-
Sep 9, 2026, 17:38Cardiovascular Health in Bleeding Disorders – EHC